We are live on ! Find out more
BIOA

BioAge Labs
BIOA

65 hedge funds and large institutions have $114M invested in BioAge Labs in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 29

12% more funds holding

Funds holding: 58 → 65 (+7)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

74% less capital invested

Capital invested by funds: $431M → $114M (-$317M)

1,149.26% less ownership

Funds ownership: 1,204.05% → 54.79% (-1,149%)

Holders
65
Holders Change
+7
Holders Change %
+12.07%
% of All Funds
0.86%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
36
Increased
11
Reduced
11
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$22.7M
2
CAM
Cormorant Asset Management
Massachusetts
+$17.2M
3
BlackRock
BlackRock
New York
+$12.3M
4
Morgan Stanley
Morgan Stanley
New York
+$7.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.46M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$20.7M
2
RCM
RA Capital Management
Massachusetts
-$15.5M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.36M
4
O
OrbiMed
New York
-$8.65M
5
Brown Advisory
Brown Advisory
Maryland
-$6.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
76
Balyasny Asset Management
Illinois
– -$2.5M -120,000 Closed
SFM
77
Soros Fund Management
New York
– -$2.08M -100,000 Closed
MIM
78
Monashee Investment Management
Massachusetts
– -$1.98M -95,000 Closed
Walleye Capital
79
Walleye Capital
New York
– -$1.6M -76,875 Closed
TD Asset Management
80
TD Asset Management
Ontario, Canada
– -$1.25M -59,678 Closed
PD
81
Point72 (DIFC)
United Arab Emirates
– -$1.15M -55,080 Closed
PIM
82
Platinum Investment Management
Australia
– -$1.04M -50,000 Closed
Jane Street
83
Jane Street
New York
– -$896K -43,073 Closed
GCM
84
Ghisallo Capital Management
Massachusetts
– -$624K -30,000 Closed
KCM
85
Kodai Capital Management
Illinois
– -$624K -30,000 Closed
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$555K -26,677 Closed
MS
87
Maven Securities
Jersey
– -$520K -25,000 Closed
Teacher Retirement System of Texas
88
Teacher Retirement System of Texas
Texas
– -$416K -20,000 Closed
LCM
89
Landscape Capital Management
New Jersey
– -$263K -12,643 Closed
Two Sigma Investments
90
Two Sigma Investments
New York
– -$239K -11,500 Closed
HF
91
HRT Financial
New York
– -$204K -9,813 Closed
ACM
92
Aster Capital Management
United Arab Emirates
– -$145K -6,988 Closed
Point72 Asset Management
93
Point72 Asset Management
Connecticut
– -$56.2K -2,700 Closed
UIA
94
Ulland Investment Advisors
Minnesota
– +$345 +20 New
1 2 3
4

BIOA Hedge Fund Activity: Q4 2024 in Review

65 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q4 2024, worth a combined $114M — down 74% from $431M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new BIOA positions and 29 closed out — a net gain of 7 holders — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $22.7M. The largest seller was AllianceBernstein, exiting entirely with an estimated $20.7M sold.

  • 65 institutional investors held BioAge Labs (BIOA) as of Q4 2024, up from 58 in Q3 2024.
  • Funds reported $114M of BioAge Labs stock for Q4 2024, down 74% quarter-over-quarter.
  • 36 funds opened new BioAge Labs positions in Q4 2024 and 29 closed out, a net change of +7 holders.
  • The largest BioAge Labs buyer in Q4 2024 was Tang Capital Management, an estimated $22.7M added.
  • The largest BioAge Labs seller in Q4 2024 was AllianceBernstein, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2024.